| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.bocsci.com | |||
![]() | +1 (631) 485-4226 | |||
![]() | +1 (631) 614-7828 | |||
![]() | info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| Hangzhou Leap Chem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.leapchem.com | |||
![]() | +86 (571) 8771-1850 | |||
![]() | market19@leapchem.com | |||
![]() | QQ Chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink Standard supplier since 2015 | ||||
| Bosche Scientific LLC, | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.boschesci.com | |||
![]() | +1 (732) 565-9988 | |||
![]() | +1 (732) 875-0899 | |||
![]() | sales@boschesci.com | |||
| Chemical manufacturer | ||||
| MP Biomedicals LLC. | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.mpbio.com | |||
![]() | +1 (440) 337-1200 | |||
![]() | +1 (440) 337-1180 | |||
![]() | inside@mpbio.com | |||
| Chemical manufacturer | ||||
| OChem Incorporation | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.ocheminc.com | |||
![]() | +1 (847) 403-7044 | |||
![]() | +1 (847) 298-5008 | |||
![]() | sales@ocheminc.com | |||
| Chemical manufacturer | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.scbt.com | |||
![]() | +1 (831) 457-3800 | |||
![]() | +1 (831) 457-3801 | |||
![]() | scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Classification | API >> Circulatory system medication >> Prevention and treatment of angina pectoris |
|---|---|
| Name | Nicardipine hydrochloride |
| Synonyms | Methyl 2-(benzyl-methyl-amino)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride |
| Molecular Structure | ![]() |
| Molecular Formula | C26H29N3O6.HCl |
| Molecular Weight | 515.99 |
| CAS Registry Number | 54527-84-3 |
| EC Number | 259-198-4 |
| Hazard Symbols | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R23/24/25 Details | ||||||||||||||||||||||||
| Safety Statements | S36/37/39;S45 Details | ||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| Transport Information | UN 2811 | ||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Nicardipine hydrochloride |